Literature DB >> 31665573

Fecal Microbiota Transplantation for Dysbiosis - Predictable Risks.

Martin J Blaser1.   

Abstract

Mesh：

Year:  2019        PMID： 31665573     DOI： 10.1056/NEJMe1913807

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Ten Reasons to Think about Bile Acids in Managing Inflammatory Bowel Disease.

Authors:  Michael Camilleri
Journal:  J Crohns Colitis       Date:  2020-08-31       Impact factor: 9.071

2.  Gut microbiome in liver pathophysiology and cholestatic liver disease.

Authors:  Shengmin Yan; Xiao-Ming Yin
Journal:  Liver Res       Date:  2021-08-08

Review 3.  Gut microbiota: a new avenue to reveal pathological mechanisms of constipation.

Authors:  Lei Yang; Yu Wang; Yun Zhang; Wenwen Li; Shu Jiang; Dawei Qian; Jinao Duan
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-03       Impact factor: 5.560

Review 4.  Gut microbiome in gastrointestinal cancer: a friend or foe?

Authors:  Yang Liu; Yoshifumi Baba; Takatsugu Ishimoto; Xi Gu; Jun Zhang; Daichi Nomoto; Kazuo Okadome; Hideo Baba; Peng Qiu
Journal:  Int J Biol Sci       Date:  2022-06-21       Impact factor: 10.750

5.  Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches.

Authors:  Sisi Lin; Subhajit Mukherjee; Juanjuan Li; Weiliang Hou; Chao Pan; Jinyao Liu
Journal:  Sci Adv       Date:  2021-05-12       Impact factor: 14.136

Review 6.  The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection: Current Understanding and Gap Analysis.

Authors:  Mark H Wilcox; Barbara H McGovern; Gail A Hecht
Journal:  Open Forum Infect Dis       Date:  2020-04-11       Impact factor: 3.835

7.  Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis.

Authors:  Yingli Jing; Fan Bai; Yan Yu; Limiao Wang; Degang Yang; Chao Zhang; Chuan Qin; Mingliang Yang; Dong Zhang; Yanbing Zhu; Jianjun Li; Zhiguo Chen
Journal:  Microbiome       Date:  2021-03-07       Impact factor: 14.650

8.  Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century.

Authors:  Magdy El-Salhy; Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

9.  A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis.

Authors:  Matthew R Henn; Edward J O'Brien; Liyang Diao; Brian G Feagan; William J Sandborn; Curtis Huttenhower; Jennifer R Wortman; Barbara H McGovern; Sherry Wang-Weigand; David I Lichter; Meghan Chafee; Christopher B Ford; Patricia Bernardo; Peng Zhao; Sheri Simmons; Amelia D Tomlinson; David N Cook; Roger J Pomerantz; Bharat K Misra; John G Auninš; Michele Trucksis
Journal:  Gastroenterology       Date:  2020-08-04       Impact factor: 22.682

10.  Lantibiotics Produced by Oral Inhabitants as a Trigger for Dysbiosis of Human Intestinal Microbiota.

Authors:  Hideo Yonezawa; Mizuho Motegi; Atsushi Oishi; Fuhito Hojo; Seiya Higashi; Eriko Nozaki; Kentaro Oka; Motomichi Takahashi; Takako Osaki; Shigeru Kamiya
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.